Ulu A

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB\/W F1 mice - Klocke_2019_Sci.Rep_9_8993
Author(s) : Klocke J , Ulu A , Wu K , Rudolph B , Dragun D , Gollasch M , Schunck WH , Hammock BD , Riemekasten G , Enghard P
Ref : Sci Rep , 9 :8993 , 2019
Abstract : Klocke_2019_Sci.Rep_9_8993
ESTHER : Klocke_2019_Sci.Rep_9_8993
PubMedSearch : Klocke_2019_Sci.Rep_9_8993
PubMedID: 31222024

Title : Inhibition of soluble epoxide hydrolase as a novel approach to high dose diazepam induced hypotension - Ulu_2016_J.Clin.Toxicol_6_
Author(s) : Ulu A , Inceoglu B , Yang J , Singh V , Vito S , Wulff H , Hammock BD
Ref : J Clinical Toxicology , 6 : , 2016
Abstract : Ulu_2016_J.Clin.Toxicol_6_
ESTHER : Ulu_2016_J.Clin.Toxicol_6_
PubMedSearch : Ulu_2016_J.Clin.Toxicol_6_
PubMedID: 28255523

Title : Aberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis model - Terry_2014_J.Vasc.Res_51_269
Author(s) : Terry CM , Carlson ML , He Y , Ulu A , Morisseau C , Blumenthal DK , Hammock BD , Cheung AK
Ref : J Vasc Res , 51 :269 , 2014
Abstract : Terry_2014_J.Vasc.Res_51_269
ESTHER : Terry_2014_J.Vasc.Res_51_269
PubMedSearch : Terry_2014_J.Vasc.Res_51_269
PubMedID: 25196102

Title : Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy - Lee_2014_J.Med.Chem_57_7016
Author(s) : Lee KS , Liu JY , Wagner KM , Pakhomova S , Dong H , Morisseau C , Fu SH , Yang J , Wang P , Ulu A , Mate CA , Nguyen LV , Hwang SH , Edin ML , Mara AA , Wulff H , Newcomer ME , Zeldin DC , Hammock BD
Ref : Journal of Medicinal Chemistry , 57 :7016 , 2014
Abstract : Lee_2014_J.Med.Chem_57_7016
ESTHER : Lee_2014_J.Med.Chem_57_7016
PubMedSearch : Lee_2014_J.Med.Chem_57_7016
PubMedID: 25079952
Gene_locus related to this paper: human-EPHX2

Title : Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP - Inceoglu_2011_Proc.Natl.Acad.Sci.U.S.A_108_5093
Author(s) : Inceoglu B , Wagner K , Schebb NH , Morisseau C , Jinks SL , Ulu A , Hegedus C , Rose T , Brosnan R , Hammock BD
Ref : Proc Natl Acad Sci U S A , 108 :5093 , 2011
Abstract : Inceoglu_2011_Proc.Natl.Acad.Sci.U.S.A_108_5093
ESTHER : Inceoglu_2011_Proc.Natl.Acad.Sci.U.S.A_108_5093
PubMedSearch : Inceoglu_2011_Proc.Natl.Acad.Sci.U.S.A_108_5093
PubMedID: 21383170

Title : Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model - Liu_2010_Biochem.Pharmacol_79_880
Author(s) : Liu JY , Yang J , Inceoglu B , Qiu H , Ulu A , Hwang SH , Chiamvimonvat N , Hammock BD
Ref : Biochemical Pharmacology , 79 :880 , 2010
Abstract : Liu_2010_Biochem.Pharmacol_79_880
ESTHER : Liu_2010_Biochem.Pharmacol_79_880
PubMedSearch : Liu_2010_Biochem.Pharmacol_79_880
PubMedID: 19896470

Title : Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model - Ulu_2008_J.Cardiovasc.Pharmacol_52_314
Author(s) : Ulu A , Davis BB , Tsai HJ , Kim IH , Morisseau C , Inceoglu B , Fiehn O , Hammock BD , Weiss RH
Ref : J Cardiovasc Pharmacol , 52 :314 , 2008
Abstract : Ulu_2008_J.Cardiovasc.Pharmacol_52_314
ESTHER : Ulu_2008_J.Cardiovasc.Pharmacol_52_314
PubMedSearch : Ulu_2008_J.Cardiovasc.Pharmacol_52_314
PubMedID: 18791465